News ArticleMore News »
Novum Attended DIA 2016 Annual Conference
May 30, 2016
Pittsburgh, PA: Members of Novum’s Scientific Affairs team, lead by Ms. Pina D’Angelo, MSc, Senior Director, Scientific Affairs (Biostatistics) attend at the upcoming 52nd DIA Annual Meeting from June 26th – 30th. Her team was accepted as a professional poster presentation on the topic of “Testing for Bioequivalence in Higher-Order Crossover Designs: Two-at-a-Time Principle Versus Pooled ANOVA”.
Novum welcomed the opportunity to speak with those interested in learning more about our full range of services. Email email@example.com for more information.
For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials; Early Phase Research from First in Human studies to large bioequivalence studies are conducted at Clinical Pharmacology units in Houston, Texas; Las Vegas, Nevada; and Fargo, North Dakota. A separate division, managing Late Phase Research requiring patient populations across multiple therapeutic areas, is lead by the Clinical Trials Division headquartered in Pittsburgh, Pennsylvania.